The reported news showcase a variety of developments for Molina Healthcare (MOH). There have been changes in stock ownership, with Asset Management One Co. Ltd and the Alaska Department of Revenue selling shares, while Mirae Asset Global Investments and KBC Group increased their stakes. MOH experienced volatility in performance, with a noticeable 17.4% rise after Q1 outperformance and reaffirmation of FY26 guidance, but also seen down trends post Q1 2026 earnings. Q1 results were positively influenced by controlled medical costs, with EPS beating estimates. Molina's regulatory environment improved with higher 2027 MA rates boosting its outlook. Despite a membership decline in Q1 2026, they reaffirmed the year's outlook. A $93M impairment impacted Q1 financials, but the 2026 targets remained intact. The company plans a $750M offering of senior notes due 2031. Molina remains focused on its Medicaid operations, moving away from MAPD. Barclays and Morgan Stanley raised their price target for MOH based on solid quarters and Medicaid trends respectively. Molina has attracted the attention of billionaire Seth Klarman and Michael Burry, who are betting on the company as a defensive value bet amidst sector turmoil.
Molina Healthcare MOH News Analytics from Mon, 10 Nov 2025 08:00:00 GMT to Sat, 25 Apr 2026 19:05:52 GMT - Rating 0 - Innovation 4 - Information 6 - Rumor 5
